• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产志贺毒素大肠杆菌O157与毒力基因stx2和eae之间的强关联可能是溶血性尿毒综合征患者中O157血清群占优势的原因。

Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.

作者信息

Werber D, Fruth A, Buchholz U, Prager R, Kramer M H, Ammon A, Tschäpe H

机构信息

Department for Infectious Disease Epidemiology, Robert Koch-Institut, Seestrasse 10, 13353 Berlin, Germany.

出版信息

Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):726-30. doi: 10.1007/s10096-003-1025-0. Epub 2003 Nov 12.

DOI:10.1007/s10096-003-1025-0
PMID:14614596
Abstract

The aim of this study was to investigate the association between Shiga toxin-producing Escherichia coli (STEC) O157 and the simultaneous presence of the virulence genes stx2 and eae in STEC from patients with gastroenteritis. In Germany, the proportion of serogroup O157 is substantially higher among STEC isolates from patients with haemolytic uraemic syndrome (HUS) than among STEC isolates from patients with gastroenteritis. The reason for this is unknown. Independent of serogroup, the virulence genes stx2 and eae have been associated with severe disease. Data collected in 2000-2001 from a Germany-wide laboratory-based surveillance system for STEC-associated gastroenteritis in patients <15 years were analysed. Overall, 18% of the STEC isolates belonged to serogroup O157. Compared with non-O157 strains, 0157 isolates were strongly associated with the simultaneous presence of both an stx2 gene and the eae gene (OR, 76; 95%CI, 27-230). Within the subset of STEC isolates that carried both virulence genes, 60% belonged to serogroup O157, a proportion similar to that found in STEC isolates from pediatric patients with HUS in Germany and Austria (67%, P=0.35). These data suggest that the more frequent carriage of both virulence genes, i.e. stx2 and eae, forms the basis of why STEC O157 predominates in patients with HUS.

摘要

本研究的目的是调查产志贺毒素大肠杆菌(STEC)O157与胃肠炎患者分离出的STEC中同时存在毒力基因stx2和eae之间的关联。在德国,溶血性尿毒综合征(HUS)患者分离出的STEC菌株中,O157血清群的比例显著高于胃肠炎患者分离出的STEC菌株。其原因尚不清楚。与血清群无关,毒力基因stx2和eae与严重疾病有关。对2000 - 2001年从德国范围内基于实验室的<15岁STEC相关性胃肠炎患者监测系统收集的数据进行了分析。总体而言,18%的STEC分离株属于O157血清群。与非O157菌株相比,O157分离株与stx2基因和eae基因同时存在密切相关(比值比,76;95%置信区间,27 - 230)。在同时携带两种毒力基因的STEC分离株亚组中,60%属于O157血清群,这一比例与德国和奥地利儿科HUS患者分离出的STEC菌株中的比例相似(67%,P = 0.35)。这些数据表明,两种毒力基因即stx2和eae更频繁的携带是STEC O157在HUS患者中占主导地位的基础。

相似文献

1
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.产志贺毒素大肠杆菌O157与毒力基因stx2和eae之间的强关联可能是溶血性尿毒综合征患者中O157血清群占优势的原因。
Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):726-30. doi: 10.1007/s10096-003-1025-0. Epub 2003 Nov 12.
2
Virulence genes, Shiga toxin subtypes, major O-serogroups, and phylogenetic background of Shiga toxin-producing Escherichia coli strains isolated from cattle in Iran.从伊朗牛群中分离出的产志贺毒素大肠杆菌菌株的毒力基因、志贺毒素亚型、主要O血清群及系统发育背景
Microb Pathog. 2017 Aug;109:274-279. doi: 10.1016/j.micpath.2017.05.041. Epub 2017 May 31.
3
Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland.2017 年瑞士人感染病例中分离出的产志贺毒素大肠杆菌菌株的血清型和毒力特征。
Int J Med Microbiol. 2018 Oct;308(7):933-939. doi: 10.1016/j.ijmm.2018.06.011. Epub 2018 Jun 30.
4
Virulence genes and intimin types of Shiga-toxin-producing Escherichia coli isolated from cattle and beef products in Argentina.从阿根廷牛和牛肉制品中分离出的产志贺毒素大肠杆菌的毒力基因和紧密黏附素类型
Int Microbiol. 2004 Dec;7(4):269-76.
5
Shiga Toxin-Producing Infection in Jönköping County, Sweden: Occurrence and Molecular Characteristics in Correlation With Clinical Symptoms and Duration of Shedding.瑞典延雪平省的产志贺毒素感染:与临床症状和排毒时间相关的发生情况及分子特征。
Front Cell Infect Microbiol. 2018 May 1;8:125. doi: 10.3389/fcimb.2018.00125. eCollection 2018.
6
Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand.从阿根廷、澳大利亚和新西兰的人类中分离出的产志贺毒素大肠杆菌O157菌株的特性分析。
BMC Microbiol. 2008 Mar 17;8:46. doi: 10.1186/1471-2180-8-46.
7
Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.产志贺毒素大肠杆菌的毒力因子与 1992-2013 年挪威溶血性尿毒综合征的发病风险。
Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1613-1620. doi: 10.1007/s10096-017-2974-z. Epub 2017 Apr 8.
8
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.携带志贺毒素2基因变体的大肠杆菌:频率及其与临床症状的关联
J Infect Dis. 2002 Jan 1;185(1):74-84. doi: 10.1086/338115. Epub 2001 Dec 14.
9
Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.法国儿童溶血性尿毒症综合征与产志贺毒素大肠杆菌感染。法国儿科肾脏病学会。
Epidemiol Infect. 2000 Apr;124(2):215-20. doi: 10.1017/s0950268899003623.
10
Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in the Netherlands, January 2008 to December 2011.2008 年 1 月至 2011 年 12 月期间,荷兰发生了人类产志贺毒素大肠杆菌(STEC)感染,其中出现了编码志贺毒素 2f 的大肠杆菌。
Euro Surveill. 2014 May 1;19(17):26-32.

引用本文的文献

1
Occurrence of Shiga-toxigenic and enteropathogenic contaminations and assessment of water quality in the southern coastal belt in Sri Lanka.斯里兰卡南部沿海地区志贺毒素产生菌和肠致病性污染的发生情况及水质评估
J Water Health. 2025 Jul;23(7):861-876. doi: 10.2166/wh.2025.353. Epub 2025 Jun 23.
2
Prevalence, Molecular Characterization, and Antimicrobial Resistance Profiles of Shiga Toxin-Producing Isolated from Raw Beef, Pork, and Chicken Meat in Vietnam.越南生牛肉、猪肉和鸡肉中分离出的产志贺毒素菌株的流行率、分子特征及抗菌药物耐药性概况
Foods. 2024 Jun 28;13(13):2059. doi: 10.3390/foods13132059.
3
Genetic Characterization of Intimin Gene () in Clinical Shiga Toxin-Producing Strains from Pediatric Patients in Finland.

本文引用的文献

1
Development of a research netwrok for emerging foodborne pathogens in Germany.德国新兴食源性病原体研究网络的发展
Euro Surveill. 2000 Nov;5(11):120-123. doi: 10.2807/esm.05.11.00005-en.
2
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.溶血尿毒综合征狒狒模型中对志贺毒素1和2的反应
Pediatr Nephrol. 2003 Feb;18(2):92-6. doi: 10.1007/s00467-002-1035-7. Epub 2003 Jan 10.
3
Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.携带stx基因的临床大肠杆菌菌株:stx变体和stx阳性毒力谱。
芬兰儿科患者产志贺毒素大肠埃希菌临床分离株中紧密素基因 () 的遗传特征。
Toxins (Basel). 2023 Nov 23;15(12):669. doi: 10.3390/toxins15120669.
4
Extended-spectrum β-lactamase-producing E. coli from retail meat and workers: genetic diversity, virulotyping, pathotyping and the antimicrobial effect of silver nanoparticles.零售肉品及其从业人员中产超广谱β-内酰胺酶大肠杆菌:遗传多样性、毒力分型、血清分型和银纳米粒子的抗菌效果。
BMC Microbiol. 2023 Aug 7;23(1):212. doi: 10.1186/s12866-023-02948-0.
5
Diagnosis and Treatment for Shiga Toxin-Producing Associated Hemolytic Uremic Syndrome.产志贺样毒素大肠埃希菌相关性溶血尿毒综合征的诊断与治疗。
Toxins (Basel). 2022 Dec 23;15(1):10. doi: 10.3390/toxins15010010.
6
Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.2000 年至 2016 年芬兰儿童患者与无溶血尿毒症综合征患者中产志贺毒素大肠埃希菌的比较基因组学研究。
Microbiol Spectr. 2022 Aug 31;10(4):e0066022. doi: 10.1128/spectrum.00660-22. Epub 2022 Jun 22.
7
The effect of two ribonucleases on the production of Shiga toxin and stx-bearing bacteriophages in Enterohaemorrhagic Escherichia coli.两种核糖核酸酶对产志贺毒素和携带 stx 的噬肠杆菌在产志贺毒素和携带 stx 的大肠杆菌中的影响。
Sci Rep. 2021 Sep 15;11(1):18372. doi: 10.1038/s41598-021-97736-z.
8
Therapeutic Uses of Bacterial Subunit Toxins.细菌亚基毒素的治疗用途
Toxins (Basel). 2021 May 26;13(6):378. doi: 10.3390/toxins13060378.
9
Genomic Insights Into Clinical Shiga Toxin-Producing Strains: A 15-Year Period Survey in Jönköping, Sweden.产志贺毒素临床菌株的基因组学见解:瑞典延雪平15年的调查研究
Front Microbiol. 2021 Feb 5;12:627861. doi: 10.3389/fmicb.2021.627861. eCollection 2021.
10
A Targeted Sequencing Assay for Serotyping Using AgriSeq Technology.一种使用AgriSeq技术进行血清分型的靶向测序检测方法。
Front Microbiol. 2021 Jan 15;11:627997. doi: 10.3389/fmicb.2020.627997. eCollection 2020.
J Clin Microbiol. 2002 Dec;40(12):4585-93. doi: 10.1128/JCM.40.12.4585-4593.2002.
4
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.1997 - 2000年德国和奥地利儿童溶血尿毒综合征中产生志贺毒素大肠杆菌感染的临床病程及作用:一项前瞻性研究
J Infect Dis. 2002 Aug 15;186(4):493-500. doi: 10.1086/341940. Epub 2002 Aug 2.
5
Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.大肠杆菌O157:H7感染:可滤过性粪便志贺毒素与疾病转归之间的不一致性
J Infect Dis. 2002 Jul 1;186(1):57-63. doi: 10.1086/341295. Epub 2002 Jun 10.
6
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.携带志贺毒素2基因变体的大肠杆菌:频率及其与临床症状的关联
J Infect Dis. 2002 Jan 1;185(1):74-84. doi: 10.1086/338115. Epub 2001 Dec 14.
7
The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.美国全国前瞻性溶血尿毒综合征研究:微生物学、血清学、临床及流行病学研究结果
J Infect Dis. 2001 Apr 1;183(7):1063-70. doi: 10.1086/319269. Epub 2001 Mar 1.
8
Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP).通过扩增的O抗原基因簇限制酶切分析(rfb-RFLP)鉴定大肠杆菌O血清群。
Res Microbiol. 2000 Oct;151(8):639-54. doi: 10.1016/s0923-2508(00)00134-0.
9
Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska.内布拉斯加州腹泻粪便样本中非O157:H7产志贺毒素大肠杆菌的流行情况
Emerg Infect Dis. 2000 Sep-Oct;6(5):530-3. doi: 10.3201/eid0605.000513.
10
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.产志贺毒素大肠杆菌的毒力因子与人类疾病之间的关联。
J Clin Microbiol. 1999 Mar;37(3):497-503. doi: 10.1128/JCM.37.3.497-503.1999.